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that this elevation of coronary sinus pressure alone is 
responsible for decreased coronary ftow and concomitant 
limitation of left ventricular function. We did not find 
such an effect. That other factors playa role in the patient 
with a Fontan circulation is beyond doubt. Indeed, every 
patient with a Fontan circulation has an inherent eleva-
tion of central venous press ure, regardless of whether the 
coronary sinus is diverted to the left atrium, and thus is 
subject to potential effects on Iymphatic drainage of the 
myocardium. We fully agree with Dr. Mehlhorn that 
myocardial edema may play an important role in de-
creased left ventricular function, as was mentioned in our 
artieIe, but this was not the subject of our study. 
The second concern Dr. Mehlhorn addresses is the 
duration of elevation of coronary venous pressure. As 
mentioned in our artieIe, this is indeed a point of concern. 
In our opinion, it is very difficuIt to coneIude from 
short-term animal studies using longer periods of elevated 
coronary sinus pressure that deterioration of myocardial 
function is indeed caused by the elevation of coronary 
sinus pressure and not by the deterioration of the animal 
preparation, wh ich is a known problem in these kinds of 
experiments. We believe that (long-term) animal studies, 
not designed to mimic the patient with a Fontan circula-
tion but aimed at answering specific questions, will help us 
understand wh at mechanisms play an important role in 
affecting the left or, rather, the systemic ventrieIe in the 
Fontan setting. 
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The Batista procedure for dilated cardiomyopathy: 
An analysis that goes beyond "hand waving" 
To the Editor: 
Considerable confusion exists regarding the physio-
logie basis of the Batista procedure, both in the litera-
ture and in the content of national presentations dis-
cussing this procedure. A typical example of this 
confusion results when the Laplace relations hip for a 
sphere is quoted: 
p = 
2 . (J'h 
R (1 ) 
Here h is the wall thickness, (J' is the wall stress, P is the 
transmural pressure, and R is the cavitary radius. It is 
typically stated that since systolic pressure is relatively 
constant, the Batista procedure, by removing mass, 
results in a decrease in radius and a proportionate 
decrease in stress. These assertions are of course valid. 
It is then asserted that the procedure has a physiologie 
benefit through a reduction in stress. This latter asser-
tion is where the argument leaves the realm of science 
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and enters the realm of imprecise reasoning ("hand 
waving"). A reduction in stress does not equate with a 
physiologie benefit per se. A simple counterexample 
makes the point. If half of the ventrieIe of anormal 
person were resected, a reduction in stress would result. 
However, removing mass from anormal ventrieIe would 
certainly not improve its function! Gf course, the 
Batista operation is beneficial only for dilated ventri-
eIes. I would then ask precisely how dilated must the 
ventricle be? From a rigorous mathematical point of 
view, the answer has not yet been provided. Wh at is 
needed and what has been lacking to date is an 
adequate theory to allow one to predict when and 
whether resection of ventricular museIe will lead to an 
increase in function. Dickstein and associates I correctly 
point out that he re function must be defined by using 
absolute indices such as cardiac output, stroke volume, 
or exercise capacity, not by using relative indices such 
as ejection fraction. 
In a recently published letter to the Editor of this 
Journal, Chanda, Kuribayashi, and Abe2 give several 
examples of situations in which reduction of ventricular 
mass leads to a reduction in calculated systolic wall 
stress. These examples confirm their hypothesis that 
removal of ventricular mass in dilated cardiomyopathy 
will lead to a decrease in wall stress. In an example of 
the somewhat specious reasoning alluded to above, 
these authors coneIude that "in dilated cardiomyopa-
thy, surgical intervention directed to chamber volume 
reduction ... would decrease the myocardial wall stress 
and hence improve the cardiac function." AIthough 
their examples are somewhat contrived, it is eIe ar that 
wall stress will be reduced but not at all eIear that 
cardiac function will improve. The actual value of the 
wall stress ca1culated by these authors in each of their 
examples is incorrect by a factor of 103 . The stress 
should be ca1culated with units of (dyne x 103 )/cm2 or 
kdyne/cm2 • The stress ca1culated in each of their exam-
pies should be corrected by replacing dyne/cm2 with 
kdyne/cm2• 
Thus the coneIusions of Chanda, Kuribayashi, and 
Abe2 that "the idea of [the Batista procedure 1 is unique 
and physiologically well-based" is overly optimistic and 
eertainly not warranted on the basis of their calcula-
tions. The fact that systolic stress decreases with ven-
tricular resection ought to be self-evident because it 
follows directly from the Laplace relationship. Con-
versely, the coneIusion of Dickstein and associates I that 
"overall pump function is depressed ... after heart 
reduction surgery" is based on an analysis, albeit de-
tailed, of a single set of geometrie and functional left 
ventricular parameters "appropriate for a 70 kg man 
with dilated cardiomyopathy." Their analysis cannot 
exeIude the possibility that there exists another entire 
set of functional and geometrie parameters for which 
the Batista procedure does lead to an improvement in 
function. Another simple counterexample makes the 
point. It is eIear that, in nature, museIe fibers can only 
generate a certain maximum amount of force per unit 
surface arca; let us call this (J' max' lt is also c1car that to 
generate a non-zero stroke volume in a living mammal, 
intraventricular pressure must exceed a minimally ac-
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ceptable systemic systolic pressure, for example, P min 
=60 mm Hg. On the basis of equation 1, it is dear that 
for a sufficiently dilated ventricle 
R> (2) 
It follows that stroke volume approach es zero! In this 
limiting case, resection of ventricular mass, by reducing R 
while keeping h constant, will obviously increase stroke 
volume to a non-zero value. In fact, if ventricular dysfunc-
tion were occurring purelyon a geometric basis (due to 
dilatation with normal intrinsic fiber contractility), an 
appropriate ventricular resection such that R/h were 
corrected to normal, would lead to areturn to normal 
function! 
These examples demonstrate that the analysis of 
Chanda, Kuribayashi, and Abe2 is overly optimistic and 
the analysis of Dickstein and coworkers l is overly 
pessimistic about the potential beneficial effects of the 
Batista procedure. There are extreme theoretical cases 
in which the Batista procedure dearly will lead to an 
increase in function in absolute terms. There are other 
extremes in which function will be worsened. In both 
cases stress will be reduced. Therefore stress reduction 
alone does not imply any particular acute effect on 
function. A more careful analysis is needed that exam-
ines the set of circumstances in between these two 
extremes. An appropriate theory should allow for a 
quantitative prediction of when and whether a benefi-
cial effect of the Batista procedure should be expected. 
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Reply to the Editor: 
It is our great pleasure to address the points raised by 
Bridges in his letter regarding our recently published 
letter. l McCarthy and associates2 have dearly described 
the indication for the Batista procedure in patients with 
dilated cardiomyopathy. Bridges has quoted the opposite 
(" ... reduction of ventricular mass leads to a reduction in 
calculated systolic stress") of what we intended to say in 
our letter: The basic principle of the Batista operation for 
dilated cardiomyopathy is not to reduce the mass of the 
ventride but to reduce the volume 01 the chamber of the 
dilated ventride, and thus to reduce the wall stress of the 
ventricle. This was our only criticism of the comment 
made by Dickstein, Spotnitz, and Burkhoff3 in their arti-
de. This was evidenced in examples 1 applying equation 7 
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cited in the text by Dickstein and colleagues? Our thanks 
to Bridges for correcting the erroneous unit of the calcu-
lated wall stress (kdyne/cm2 instead of dyne/cm2), which 
was inadvertently overlooked. Although the judgment of 
"optimism" and "pessimism" goes beyond "hand waving," 
one should take into the account that the expected 
survival after transplantation would be only 5% over the 
subsequent year for patients waiting 6 months, wh ich is 
the waiting time for many outpatients.4 
In our letter l we have discussed the import an ce of left 
ventricular mass/left ventricular end-systolic volume 
(L VM/LVESV) ratio and left ventricular mass/left ven-
tricular end-diastolic volume (LVM/LVEDV) ratio on 
prognosis of survivals of patients with dilated cardiomy-
opathy. The survival was significantly high er for patients 
with an L VM/L VEDV ratio greater than 0.90 as com-
pared with those with an L VM/L VEDV ratio less than 
0.90.5 The calculated value of mean LVM/LVESV ratio in 
survivors and nonsurvivors with dilated cardiomyopathl 
was 1.36 and 1.06, respectively.1 Similarly, in another 
report in patients with compensated dilated cardiomyop-
athy,1 the calculated me an L VM/L VESV ratio (1.8) was 
higher than that (1.09) in patients with decompensated 
dilated cardiomyopathy. 1 
On the basis of our present and previous discus-
sion, I. H, ') we speculate that patients with end-stage dilated 
cardiomyopathy with L VM/L VESV and L VM/L VEDV 
ratios less than 1.3 and 0.9, respectively, would be candi-
dates for ventricular chamber volume reduction; intracav-
ity patch-employed partial ventriculectomy and muscle-
sparing chamber volume reduction would be the strategies 
when myocardial thickness is more (or equal to) and less 
than 10 mm, respectively. 
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